Partnerships, Licensing, Investments and MandA Deals and Trends in Pharmaceuticals - Q1 2018

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2018

Summary

"Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2018", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q1 2018. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and womens health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the five quarters.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.


1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q1 2018 10
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q1 2018 10
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q1 2018 12
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q1 2018 13
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2018 14
2.4.1 GlaxoSmithKline to Acquire Remaining 36.5% Stake in GlaxoSmithKline Consumer Healthcare from Novartis for USD13 Billion 14
2.4.2 Sanofi Acquires Bioverativ for USD11.5 Billion in Tender Offer 15
2.4.3 Celgene Acquires Juno Therapeutics for USD9 Billion 15
2.4.4 Celgene Acquires Impact Biomedicines for up to USD7 Billion 16
2.4.5 Sanofi Prices Public Offering Notes for USD9.9 Billion 16
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 17
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q1 2018 17
3.1.1 Top M&A Deals in Q1 2018 18
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q1 2017 - Q1 2018 19
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q1 2018 20
3.2.1 Top Initial Public Offerings in Q1 2018 21
3.2.2 Top Secondary Offerings in Q1 2018 21
3.2.3 Top PIPE Deals in Q1 2018 22
3.2.4 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q1 2017 - Q1 2018 22
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q1 2018 24
3.3.1 Top Venture Financing Deals in Q1 2018 25
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2018 25
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2018 26
3.3.5 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q1 2017 - Q1 2018 27
3.3.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q1 2017 - Q1 2018 28
3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q1 2017 - Q1 2018 29
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q1 2018 30
3.4.1 Top Private Equity Deals in Q1 2018 31
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q1 2017 - Q1 2018 31
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2018 33
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2018 33
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q1 2017 - Q1 2018 34
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 35
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q1 2018 36
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2018 36
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q1 2018 37
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 38
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q1 2017 - Q1 2018 40
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q1 2017 - Q1 2018 41
4.8 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 42
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q1 2018 44
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q1 2018 44
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 45
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q1 2018 46
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q1 2018 46
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q1 2018 47
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q1 2017 - Q1 2018 48
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q1 2017 - Q1 2018 49
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2017 - Q1 2018 51
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2017 - Q1 2018 52
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q1 2017 - Q1 2018 54
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 56
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q1 2018 56
6.1.1 Oncology - Deals of the Quarter 58
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q1 2018 60
6.2.1 Central Nervous System - Deals of the Quarter 61
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q1 2018 63
6.3.1 Infectious Disease - Deals of the Quarter 64
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q1 2018 66
6.4.1 Immunology - Deals of the Quarter 67
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q1 2018 69
6.5.1 Metabolic Disorders - Deals of the Quarter 70
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q1 2018 72
6.6.1 Cardiovascular - Deals of the Quarter 73
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q1 2018 75
6.7.1 Gastrointestinal - Deals of the Quarter 76
6.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q1 2018 78
6.8.1 Dermatology - Deals of the Quarter 79
6.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q1 2018 81
6.9.1 Respiratory - Deals of the Quarter 82
6.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q1 2018 83
6.10.1 Ophthalmology - Deals of the Quarter 84
7 Deal Summary by Geography 86
7.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q1 2018 86
7.1.1 North America - Deals of the Quarter 87
7.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q1 2018 89
7.2.1 Europe - Deals of the Quarter 90
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q1 2018 91
7.3.1 Asia-Pacific - Deals of the Quarter 92
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q1 2018 93
7.4.1 Rest of the World - Deals of the Quarter 94
8 Pharmaceuticals & Healthcare, Global, Top Advisors 95
8.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q1 2017 - Q1 2018 95
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q1 2017 - Q1 2018 96
9 Further Information 97
9.1 Methodology 97
9.2 About GlobalData 98
9.3 Contact Us 98
9.4 Disclosure information 99
9.5 Disclaimer 99

List Of Tables

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 11
Table 2: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), Q1 2018 13
Table 3: Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2018 14
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 18
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, Q1 2018 18
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, , Q1 2017 - Q1 2018 19
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 21
Table 8: Pharmaceuticals & Healthcare, Global, Top Initial Public Offering Deals, Q1 2018 21
Table 9: Pharmaceuticals & Healthcare, Global, Top Secondary Offering Deals, Q1 2018 21
Table 10: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, Q1 2018 22
Table 11: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 23
Table 12: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 24
Table 13: Pharmaceuticals & Healthcare, Global, Top Venture Capital Deals, Q1 2018 25
Table 14: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), Q1 2018 26
Table 15: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 27
Table 16: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 28
Table 17: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q1 2017 - Q1 2018 29
Table 18: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 30
Table 19: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q1 2018 31
Table 20: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 32
Table 21: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 33
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 34
Table 23: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 35
Table 24: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 36
Table 25: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2018 36
Table 26: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q1 2018 37
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2017 - Q1 2018 39
Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2017 - Q1 2018 41
Table 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2017 - Q1 2018 43
Table 30: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 44
Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 45
Table 32: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Deal Values, Q1 2018 46
Table 33: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Upfront Payment, Q1 2018 46
Table 34: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Milestone Payment, Q1 2018 47
Table 35: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 48
Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment (US$ m), Q1 2017 - Q1 2018 50
Table 37: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2017 - Q1 2018 53
Table 38: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2017 - Q1 2018 55
Table 39: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 57
Table 40: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 61
Table 41: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 64
Table 42: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 67
Table 43: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 70
Table 44: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 73
Table 45: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 76
Table 46: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 79
Table 47: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 82
Table 48: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 84
Table 49: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 87
Table 50: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 90
Table 51: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 92
Table 52: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 94
Table 53: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 95
Table 54: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 96

List Of Figures

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 10
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), Q1 2018 12
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), Q1 2018 13
Figure 4: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 17
Figure 5: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q1 2017 - Q1 2018 19
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 20
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), Q1 2017 - Q1 2018 22
Figure 8: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 24
Figure 9: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q1 2018 25
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q1 2018 26
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q1 2017 - Q1 2018 27
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 28
Figure 13: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 30
Figure 14: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q1 2017 - Q1 2018 31
Figure 15: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 33
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 34
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2017 - Q1 2018 35
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2017 - Q1 2018 38
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2017 - Q1 2018 40
Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2017 - Q1 2018 41
Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2017 - Q1 2018 42
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 44
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 45
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 48
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 49
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, Q1 2017 - Q1 2018 51
Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q1 2017 - Q1 2018 52
Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2017 - Q1 2018 54
Figure 29: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 56
Figure 30: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 60
Figure 31: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 63
Figure 32: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 66
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 69
Figure 34: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 72
Figure 35: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 75
Figure 36: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 78
Figure 37: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 81
Figure 38: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 83
Figure 39: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 86
Figure 40: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 89
Figure 41: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 91
Figure 42: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 93
Figure 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 95
Figure 44: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2017 - Q1 2018 96

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in PharmaceuticalsPartnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in Pharmaceuticals report is an essential source

USD 1000 View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in PharmaceuticalsPartnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals report is an essential source

USD 1000 View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in PharmaceuticalsPartnerships, Licensing, Investments and M&A Deals and Trends for June 2018 in Pharmaceuticals report is an essential source

USD 1000 View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in PharmaceuticalsPartnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals report is an essential source

USD 1000 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available